Zacks Investment ResearchWed, 06 May 2026 13:31:16 GMTX4 Pharmaceuticals (XFOR) Reports Q1 Loss, Lags Revenue EstimatesXFOR-2.53%
Zacks Investment ResearchTue, 17 Mar 2026 13:26:08 GMTX4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue EstimatesXFOR-2.53%
Seeking AlphaTue, 03 Mar 2026 15:04:28 GMTX4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA ApprovalXFOR-2.53%
Seeking AlphaMon, 16 Feb 2026 22:57:36 GMTX4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 TranscriptXFOR-2.53%